Latest news in cancer
Understanding BCMA: A Revolutionary Target in Cancer Treatment
Introduction In the ever-evolving realm of oncological treatment, scientists persistently seek out unconventional targets that can amplify the effectiveness of...
Human-Based CAR T Cell Therapy: Breakthroughs and Challenges
Human-based CAR T-cell therapy revolutionizes cancer treatment by genetically modifying a patient's own immune cells to target and destroy cancer cells. By...
Understanding Cytokine Release Syndrome: Causes, Symptoms, and Treatment
Cytokine Release Syndrome (CRS) is an immune system reaction often triggered by certain treatments like immunotherapy or CAR-T cell therapy. It involves an...
Role of paramedics in the success of CAR T Cell therapy
Paramedics play a crucial role in the success of CAR T-cell therapy by ensuring seamless patient care throughout the treatment process. They provide vital...
How Targeted Therapy is Revolutionizing Advanced Cancer Treatment?
In the field of oncology, the emergence of targeted therapy has revolutionized the treatment landscape for advanced cancers. Unlike conventional chemotherapy,...
Utilizing Immunotherapy to Treat Late-Stage Cancers
Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have...
Survivorship and long-term care in advanced cancers
Dive into the complexities of survivorship and long-term care for individuals facing advanced cancers. Discover the latest advancements in care coordination...
FasTCAR-T GC012F demonstrated overall 100% response rate in newly diagnosed multiple myeloma
Introduction Even in transplant-eligible (TE) patients, typical first-line treatments for high-risk (HR) newly-diagnosed multiple myeloma (NDMM) have dismal...
CAR T Cell therapy for AIDS related B-Cell malignancies
CAR T cell therapy for HIV-related B cell malignancies involves genetically modifying a patient's T cells to express chimeric antigen receptors (CARs)...
Cancer statistics in India 2024: Incidence, estimates and projections
In 2024, cancer will remain a significant health challenge in India. The country sees over 1.5 million new cases a year. Breast and oral cancers are most...
India declared cancer capital of the world – Apollo report
India declared cancer capital of the world India was designated as the “cancer capital of the world” in the 4th edition of Apollo Hospitals’...
Mirvetuximab soravtansine-gynx is approved by the USFDA for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
March 2024: The Food and Drug Administration has granted approval for mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [now a part of AbbVie]) to be...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.